Search

Your search keyword '"Andersen, Claus L."' showing total 332 results
Start Over Author "Andersen, Claus L."
332 results on '"Andersen, Claus L."'

1. Detection of circulating tumor DNA by tumor-informed whole-genome sequencing enables prediction of recurrence in stage III colorectal cancer patients

Author

Frydendahl, Amanda, Nors, Jesper, Rasmussen, Mads H., Henriksen, Tenna V., Nesic, Marijana, Reinert, Thomas, Afterman, Danielle, Lauterman, Tomer, Kuzman, Maja, Gonzalez, Santiago, Glavas, Dunja, Smadback, James, Maloney, Dillon, Levatic, Jurica, Yahalom, Michael, Ptashkin, Ryan, Tavassoly, Iman, Donenhirsh, Zohar, White, Eric, Kandasamy, Ravi, Alon, Ury, Nordentoft, Iver, Lindskrog, Sia V., Dyrskjøt, Lars, Jaensch, Claudia, Løve, Uffe S., Andersen, Per V., Thorlacius-Ussing, Ole, Iversen, Lene H., Gotschalck, Kåre A., Zviran, Asaf, Oklander, Boris, and Andersen, Claus L.

Published
2024
Full Text
View/download PDF

4. Beyond basics: Key mutation selection features for successful tumor‐informed ctDNA detection.

Author

Nesic, Marijana, Rasmussen, Mads H., Henriksen, Tenna V., Demuth, Christina, Frydendahl, Amanda, Nordentoft, Iver, Dyrskjøt, Lars, and Andersen, Claus L.

Subjects
CIRCULATING tumor DNA, BLADDER cancer, GENETIC mutation, SOMATIC mutation, ERROR rates
Abstract

Tumor‐informed mutation‐based approaches are frequently used for detection of circulating tumor DNA (ctDNA). Not all mutations make equally effective ctDNA markers. The objective was to explore if prioritizing mutations using mutational features—such as cancer cell fraction (CCF), multiplicity, and error rate—would improve the success rate of tumor‐informed ctDNA analysis. Additionally, we aimed to develop a practical and easily implementable analysis pipeline for identifying and prioritizing candidate mutations from whole‐exome sequencing (WES) data. We analyzed WES and ctDNA data from three tumor‐informed ctDNA studies, one on bladder cancer (Cohort A) and two on colorectal cancer (Cohorts I and N). The studies included 390 patients. For each patient, a unique set of mutations (median mutations/patient: 6, interquartile 13, range: 1–46, total n = 4023) were used as markers of ctDNA. The tool PureCN was used to assess the CCF and multiplicity of each mutation. High‐CCF mutations were detected more frequently than low‐CCF mutations (Cohort A: odds ratio [OR] 20.6, 95% confidence interval [CI] 5.72–173, p = 1.73e−12; Cohort I: OR 2.24, 95% CI 1.44–3.52, p = 1.66e−04; and Cohort N: OR 1.78, 95% CI 1.14–2.79, p = 7.86e−03). The detection‐likelihood was additionally improved by selecting mutations with multiplicity of two or above (Cohort A: OR 1.55, 95% CI 1. 14–2.11, p = 3.85e−03; Cohort I: OR 1.78, 95% CI 1.23–2.56, p = 1.34e−03; and Cohort N: OR 1.94, 95% CI 1.63–2.31, p = 2.83e−14). Furthermore, selecting the mutations for which the ctDNA detection method had the lowest error rates, additionally improved the detection‐likelihood, particularly evident when plasma cell‐free DNA tumor fractions were below 0.1% (p = 2.1e−07). Selecting mutational markers with high CCF, high multiplicity, and low error rate significantly improve ctDNA detection likelihood. We provide free access to the analysis pipeline enabling others to perform qualified prioritization of mutations for tumor‐informed ctDNA analysis. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

9. Publisher Correction: MethCORR modelling of methylomes from formalin-fixed paraffin-embedded tissue enables characterization and prognostication of colorectal cancer

Author

Mattesen, Trine B., Rasmussen, Mads H., Sandoval, Juan, Ongen, Halit, Árnadóttir, Sigrid S., Gladov, Josephine, Martinez-Cardus, Anna, de Moura, Manuel Castro, Madsen, Anders H., Laurberg, Søren, Dermitzakis, Emmanouil T., Esteller, Manel, Andersen, Claus L., and Bramsen, Jesper B.

Published
2020
Full Text
View/download PDF

11. SNHG16 is regulated by the Wnt pathway in colorectal cancer and affects genes involved in lipid metabolism

Author

Christensen, Lise Lotte, True, Kirsten, Hamilton, Mark P., Nielsen, Morten M., Damas, Nkerorema D., Damgaard, Christian K., Ongen, Halit, Dermitzakis, Emmanouil, Bramsen, Jesper B., Pedersen, Jakob S., Lund, Anders H., Vang, Søren, Stribolt, Katrine, Madsen, Mogens R., Laurberg, Søren, McGuire, Sean E., Ørntoft, Torben F., and Andersen, Claus L.

Published
2016
Full Text
View/download PDF

13. Table S1-6 from Clinical Implications of Monitoring Circulating Tumor DNA in Patients with Colorectal Cancer

Author

Schøler, Lone V., primary, Reinert, Thomas, primary, Ørntoft, Mai-Britt W., primary, Kassentoft, Christine G., primary, Árnadóttir, Sigrid S., primary, Vang, Søren, primary, Nordentoft, Iver, primary, Knudsen, Michael, primary, Lamy, Philippe, primary, Andreasen, Ditte, primary, Mortensen, Frank V., primary, Knudsen, Anders R., primary, Stribolt, Katrine, primary, Sivesgaard, Kim, primary, Mouritzen, Peter, primary, Nielsen, Hans J., primary, Laurberg, Søren, primary, Ørntoft, Torben F., primary, and Andersen, Claus L., primary

Published
2023
Full Text
View/download PDF

15. Figure S4 from Clinical Implications of Monitoring Circulating Tumor DNA in Patients with Colorectal Cancer

Author

Schøler, Lone V., primary, Reinert, Thomas, primary, Ørntoft, Mai-Britt W., primary, Kassentoft, Christine G., primary, Árnadóttir, Sigrid S., primary, Vang, Søren, primary, Nordentoft, Iver, primary, Knudsen, Michael, primary, Lamy, Philippe, primary, Andreasen, Ditte, primary, Mortensen, Frank V., primary, Knudsen, Anders R., primary, Stribolt, Katrine, primary, Sivesgaard, Kim, primary, Mouritzen, Peter, primary, Nielsen, Hans J., primary, Laurberg, Søren, primary, Ørntoft, Torben F., primary, and Andersen, Claus L., primary

Published
2023
Full Text
View/download PDF

16. Supplementary Figure legends from Clinical Implications of Monitoring Circulating Tumor DNA in Patients with Colorectal Cancer

Author

Schøler, Lone V., primary, Reinert, Thomas, primary, Ørntoft, Mai-Britt W., primary, Kassentoft, Christine G., primary, Árnadóttir, Sigrid S., primary, Vang, Søren, primary, Nordentoft, Iver, primary, Knudsen, Michael, primary, Lamy, Philippe, primary, Andreasen, Ditte, primary, Mortensen, Frank V., primary, Knudsen, Anders R., primary, Stribolt, Katrine, primary, Sivesgaard, Kim, primary, Mouritzen, Peter, primary, Nielsen, Hans J., primary, Laurberg, Søren, primary, Ørntoft, Torben F., primary, and Andersen, Claus L., primary

Published
2023
Full Text
View/download PDF

17. List of Supplementary Tables from Clinical Implications of Monitoring Circulating Tumor DNA in Patients with Colorectal Cancer

Author

Schøler, Lone V., primary, Reinert, Thomas, primary, Ørntoft, Mai-Britt W., primary, Kassentoft, Christine G., primary, Árnadóttir, Sigrid S., primary, Vang, Søren, primary, Nordentoft, Iver, primary, Knudsen, Michael, primary, Lamy, Philippe, primary, Andreasen, Ditte, primary, Mortensen, Frank V., primary, Knudsen, Anders R., primary, Stribolt, Katrine, primary, Sivesgaard, Kim, primary, Mouritzen, Peter, primary, Nielsen, Hans J., primary, Laurberg, Søren, primary, Ørntoft, Torben F., primary, and Andersen, Claus L., primary

Published
2023
Full Text
View/download PDF

18. Supplementary Figures 1-3 from Diagnostic and Prognostic MicroRNAs in Stage II Colon Cancer

Author

Schepeler, Troels, primary, Reinert, Jørgen T., primary, Ostenfeld, Marie S., primary, Christensen, Lise L., primary, Silahtaroglu, Asli N., primary, Dyrskjøt, Lars, primary, Wiuf, Carsten, primary, Sørensen, Frank J., primary, Kruhøffer, Mogens, primary, Laurberg, Søren, primary, Kauppinen, Sakari, primary, Ørntoft, Torben F., primary, and Andersen, Claus L., primary

Published
2023
Full Text
View/download PDF

19. Supplementary Table 4 from Genomic Profiling of MicroRNAs in Bladder Cancer: miR-129 Is Associated with Poor Outcome and Promotes Cell Death In vitro

Author

Dyrskjøt, Lars, primary, Ostenfeld, Marie S., primary, Bramsen, Jesper B., primary, Silahtaroglu, Asli N., primary, Lamy, Philippe, primary, Ramanathan, Ramshanker, primary, Fristrup, Niels, primary, Jensen, Jens L., primary, Andersen, Claus L., primary, Zieger, Karsten, primary, Kauppinen, Sakari, primary, Ulhøi, Benedicte P., primary, Kjems, Jørgen, primary, Borre, Michael, primary, and Ørntoft, Torben F., primary

Published
2023
Full Text
View/download PDF

21. Supplementary Figure 1 from Genomic Profiling of MicroRNAs in Bladder Cancer: miR-129 Is Associated with Poor Outcome and Promotes Cell Death In vitro

Author

Dyrskjøt, Lars, primary, Ostenfeld, Marie S., primary, Bramsen, Jesper B., primary, Silahtaroglu, Asli N., primary, Lamy, Philippe, primary, Ramanathan, Ramshanker, primary, Fristrup, Niels, primary, Jensen, Jens L., primary, Andersen, Claus L., primary, Zieger, Karsten, primary, Kauppinen, Sakari, primary, Ulhøi, Benedicte P., primary, Kjems, Jørgen, primary, Borre, Michael, primary, and Ørntoft, Torben F., primary

Published
2023
Full Text
View/download PDF

23. Supplementary Table 2 from Genomic Profiling of MicroRNAs in Bladder Cancer: miR-129 Is Associated with Poor Outcome and Promotes Cell Death In vitro

Author

Dyrskjøt, Lars, primary, Ostenfeld, Marie S., primary, Bramsen, Jesper B., primary, Silahtaroglu, Asli N., primary, Lamy, Philippe, primary, Ramanathan, Ramshanker, primary, Fristrup, Niels, primary, Jensen, Jens L., primary, Andersen, Claus L., primary, Zieger, Karsten, primary, Kauppinen, Sakari, primary, Ulhøi, Benedicte P., primary, Kjems, Jørgen, primary, Borre, Michael, primary, and Ørntoft, Torben F., primary

Published
2023
Full Text
View/download PDF

24. Supplementary Table 3 from Genomic Profiling of MicroRNAs in Bladder Cancer: miR-129 Is Associated with Poor Outcome and Promotes Cell Death In vitro

Author

Dyrskjøt, Lars, primary, Ostenfeld, Marie S., primary, Bramsen, Jesper B., primary, Silahtaroglu, Asli N., primary, Lamy, Philippe, primary, Ramanathan, Ramshanker, primary, Fristrup, Niels, primary, Jensen, Jens L., primary, Andersen, Claus L., primary, Zieger, Karsten, primary, Kauppinen, Sakari, primary, Ulhøi, Benedicte P., primary, Kjems, Jørgen, primary, Borre, Michael, primary, and Ørntoft, Torben F., primary

Published
2023
Full Text
View/download PDF

25. Supplementary Table 6 from Genomic Profiling of MicroRNAs in Bladder Cancer: miR-129 Is Associated with Poor Outcome and Promotes Cell Death In vitro

Author

Dyrskjøt, Lars, primary, Ostenfeld, Marie S., primary, Bramsen, Jesper B., primary, Silahtaroglu, Asli N., primary, Lamy, Philippe, primary, Ramanathan, Ramshanker, primary, Fristrup, Niels, primary, Jensen, Jens L., primary, Andersen, Claus L., primary, Zieger, Karsten, primary, Kauppinen, Sakari, primary, Ulhøi, Benedicte P., primary, Kjems, Jørgen, primary, Borre, Michael, primary, and Ørntoft, Torben F., primary

Published
2023
Full Text
View/download PDF

26. Supplementary Table 1 from Genomic Profiling of MicroRNAs in Bladder Cancer: miR-129 Is Associated with Poor Outcome and Promotes Cell Death In vitro

Author

Dyrskjøt, Lars, primary, Ostenfeld, Marie S., primary, Bramsen, Jesper B., primary, Silahtaroglu, Asli N., primary, Lamy, Philippe, primary, Ramanathan, Ramshanker, primary, Fristrup, Niels, primary, Jensen, Jens L., primary, Andersen, Claus L., primary, Zieger, Karsten, primary, Kauppinen, Sakari, primary, Ulhøi, Benedicte P., primary, Kjems, Jørgen, primary, Borre, Michael, primary, and Ørntoft, Torben F., primary

Published
2023
Full Text
View/download PDF

27. Data from Diagnostic and Prognostic MicroRNAs in Stage II Colon Cancer

Author

Schepeler, Troels, primary, Reinert, Jørgen T., primary, Ostenfeld, Marie S., primary, Christensen, Lise L., primary, Silahtaroglu, Asli N., primary, Dyrskjøt, Lars, primary, Wiuf, Carsten, primary, Sørensen, Frank J., primary, Kruhøffer, Mogens, primary, Laurberg, Søren, primary, Kauppinen, Sakari, primary, Ørntoft, Torben F., primary, and Andersen, Claus L., primary

Published
2023
Full Text
View/download PDF

28. Supplementary Figure 2 from Genomic Profiling of MicroRNAs in Bladder Cancer: miR-129 Is Associated with Poor Outcome and Promotes Cell Death In vitro

Author

Dyrskjøt, Lars, primary, Ostenfeld, Marie S., primary, Bramsen, Jesper B., primary, Silahtaroglu, Asli N., primary, Lamy, Philippe, primary, Ramanathan, Ramshanker, primary, Fristrup, Niels, primary, Jensen, Jens L., primary, Andersen, Claus L., primary, Zieger, Karsten, primary, Kauppinen, Sakari, primary, Ulhøi, Benedicte P., primary, Kjems, Jørgen, primary, Borre, Michael, primary, and Ørntoft, Torben F., primary

Published
2023
Full Text
View/download PDF

30. Supplementary Tables 1-4 from Diagnostic and Prognostic MicroRNAs in Stage II Colon Cancer

Author

Schepeler, Troels, primary, Reinert, Jørgen T., primary, Ostenfeld, Marie S., primary, Christensen, Lise L., primary, Silahtaroglu, Asli N., primary, Dyrskjøt, Lars, primary, Wiuf, Carsten, primary, Sørensen, Frank J., primary, Kruhøffer, Mogens, primary, Laurberg, Søren, primary, Kauppinen, Sakari, primary, Ørntoft, Torben F., primary, and Andersen, Claus L., primary

Published
2023
Full Text
View/download PDF

32. Supplementary Table 5 from Genomic Profiling of MicroRNAs in Bladder Cancer: miR-129 Is Associated with Poor Outcome and Promotes Cell Death In vitro

Author

Dyrskjøt, Lars, primary, Ostenfeld, Marie S., primary, Bramsen, Jesper B., primary, Silahtaroglu, Asli N., primary, Lamy, Philippe, primary, Ramanathan, Ramshanker, primary, Fristrup, Niels, primary, Jensen, Jens L., primary, Andersen, Claus L., primary, Zieger, Karsten, primary, Kauppinen, Sakari, primary, Ulhøi, Benedicte P., primary, Kjems, Jørgen, primary, Borre, Michael, primary, and Ørntoft, Torben F., primary

Published
2023
Full Text
View/download PDF

33. Supplementary Figure 3 from Genomic Profiling of MicroRNAs in Bladder Cancer: miR-129 Is Associated with Poor Outcome and Promotes Cell Death In vitro

Author

Dyrskjøt, Lars, primary, Ostenfeld, Marie S., primary, Bramsen, Jesper B., primary, Silahtaroglu, Asli N., primary, Lamy, Philippe, primary, Ramanathan, Ramshanker, primary, Fristrup, Niels, primary, Jensen, Jens L., primary, Andersen, Claus L., primary, Zieger, Karsten, primary, Kauppinen, Sakari, primary, Ulhøi, Benedicte P., primary, Kjems, Jørgen, primary, Borre, Michael, primary, and Ørntoft, Torben F., primary

Published
2023
Full Text
View/download PDF

34. Establishment and characterization of models of chemotherapy resistance in colorectal cancer: Towards a predictive signature of chemoresistance

Author

Jensen, Niels F., Stenvang, Jan, Beck, Mette K., Hanáková, Barbora, Belling, Kirstine C., Do, Khoa N., Viuff, Birgitte, Nygård, Sune B., Gupta, Ramneek, Rasmussen, Mads H., Tarpgaard, Line S., Hansen, Tine P., Budinská, Eva, Pfeiffer, Per, Bosman, Fred, Tejpar, Sabine, Roth, Arnaud, Delorenzi, Mauro, Andersen, Claus L., Rømer, Maria U., Brünner, Nils, and Moreira, José M.A.

Published
2015
Full Text
View/download PDF

35. ctDNA-guided adjuvant chemotherapy for colorectal cancer—ready for prime time?

Author

Andersen, Claus L and Heitzer, Ellen

Subjects
Cancer Research, Neoplasm Recurrence, Local/drug therapy, Circulating Tumor DNA/genetics, Oncology, Chemotherapy, Adjuvant, Humans, Colorectal Neoplasms/drug therapy, Prospective Studies, Neoplasm Staging
Abstract

In stage II colorectal cancer, adjuvant chemotherapy is controversial, and overtreatment is substantial due to suboptimal risk stratification. In a recent New England Journal of Medicine article reporting from a prospective randomized phase II trial, Tie and colleagues demonstrate how ctDNA-guided risk-stratification reduces the use of adjuvant chemotherapy without compromising recurrence risk.

Published
2022
Full Text
View/download PDF

36. Additional file 1 of DREAMS: deep read-level error model for sequencing data applied to low-frequency variant calling and circulating tumor DNA detection

Author

Christensen, Mikkel H., Drue, Simon O., Rasmussen, Mads H., Frydendahl, Amanda, Lyskjær, Iben, Demuth, Christina, Nors, Jesper, Gotschalck, Kåre A., Iversen, Lene H., Andersen, Claus L., and Pedersen, Jakob Skou

Abstract

Additional file 1. Supplementary material, Supplementary methods, tables, and figures [12, 16, 24, 33, 35–43].

Published
2023
Full Text
View/download PDF

38. A Dual Program for Translation Regulation in Cellular Proliferation and Differentiation

Author

Gingold, Hila, Tehler, Disa, Christoffersen, Nanna R., Nielsen, Morten M., Asmar, Fazila, Kooistra, Susanne M., Christophersen, Nicolaj S., Christensen, Lise Lotte, Borre, Michael, Sørensen, Karina D., Andersen, Lars D., Andersen, Claus L., Hulleman, Esther, Wurdinger, Tom, Ralfkiær, Elisabeth, Helin, Kristian, Grønbæk, Kirsten, Ørntoft, Torben, Waszak, Sebastian M., Dahan, Orna, Pedersen, Jakob Skou, Lund, Anders H., and Pilpel, Yitzhak

Published
2014
Full Text
View/download PDF

40. DREAMS: Deep Read-level Error Model for Sequencing data applied to low-frequency variant calling and circulating tumor DNA detection

Author

Christensen, Mikkel H., primary, Drue, Simon, additional, Rasmussen, Mads H., additional, Frydendahl, Amanda, additional, Lyskjær, Iben, additional, Demuth, Christina, additional, Nors, Jesper, additional, Gotschalck, Kåre A., additional, Iversen, Lene H., additional, Andersen, Claus L., additional, and Pedersen, Jakob Skou, additional

Published
2022
Full Text
View/download PDF

42. A genetically inducible porcine model of intestinal cancer

Author

Callesen, Morten M., Árnadóttir, Sigrid S., Lyskjær, Iben, Ørntoft, Mai‐Britt W., Høyer, Søren, Dagnæs‐Hansen, Frederik, Liu, Ying, Li, Rong, Callesen, Henrik, Rasmussen, Mads H., Berthelsen, Martin F., Thomsen, Martin K., Schweiger, Pawel J., Jensen, Kim B., Laurberg, Søren, Ørntoft, Torben F., Elverløv‐Jakobsen, Jannik E., and Andersen, Claus L.

Published
2017
Full Text
View/download PDF

45. Tumour-agnostic circulating tumour DNA analysis for improved recurrence surveillance after resection of colorectal liver metastases: A prospective cohort study

Author

Øgaard, Nadia, primary, Reinert, Thomas, additional, Henriksen, Tenna V., additional, Frydendahl, Amanda, additional, Aagaard, Emilie, additional, Ørntoft, Mai-Britt W., additional, Larsen, Marie Ø., additional, Knudsen, Anders R., additional, Mortensen, Frank V., additional, and Andersen, Claus L., additional

Published
2022
Full Text
View/download PDF

46. Putative cis-regulatory drivers in colorectal cancer

Author

Ongen, Halit, Andersen, Claus L., Bramsen, Jesper B., Oster, Bodil, Rasmussen, Mads H., Ferreira, Pedro G., Sandoval, Juan, Vidal, Enrique, Whiffin, Nicola, Planchon, Alexandra, Padioleau, Ismael, Bielser, Deborah, Romano, Luciana, Tomlinson, Ian, Houlston, Richard S., Esteller, Manel, Orntoft, Torben F., and Dermitzakis, Emmanouil T.

Subjects
Oncology, Experimental, Gene expression -- Research, Genetic research, Quantitative trait loci -- Identification and classification, Colorectal cancer -- Development and progression -- Genetic aspects, Cancer -- Research, Environmental issues, Science and technology, Zoology and wildlife conservation
Abstract

The cis-regulatory effects responsible for cancer development have not been as extensively studied as the perturbations of the protein coding genome in tumorigenesis (1,2). To better characterize colorectal cancer (CRC) development we conducted an RNA-sequencing experiment of 103 matched tumour and normal colon mucosa samples from Danish CRC patients, 90 of which were germline-genotyped. By investigating allele-specific expression (ASE) we show that the germline genotypes remain important determinants of allelic gene expression in tumours. Using the changes in ASE in matched pairs of samples we discover 71 genes with excess of somatic cis-regulatory effects in CRC, suggesting a cancer driver role. We correlate genotypes and gene expression to identify expression quantitative trait loci (eQTLs) and find 1,693 and 948 eQTLs in normal samples and tumours, respectively. We estimate that 36% of the tumour eQTLs are exclusive to CRC and show that this specificity is partially driven by increased expression of specific transcription factors and changes in methylation patterns. We show that tumour-specific eQTLs are more enriched for low CRC genome-wide association study (GWAS) P values than shared eQTLs, which suggests that some of the GWAS variants are tumour specific regulatory variants. Importantly, tumour-specific eQTL genes also accumulate more somatic mutations when compared to the shared eQTL genes, raising the possibility that they constitute germline-derived cancer regulatory drivers. Collectively the integration of genome and the transcriptome reveals a substantial number of putative somatic and germline cis-regulatory cancer changes that may have a role in tumorigenesis., The non-coding genome has so far been overlooked in the search for drivers in cancer, except for some isolated examples (1,2). The genome contains regulatory non-coding germline variation affecting gene [...]

Published
2014

49. Correction: Corrigendum: A DERL3-associated defect in the degradation of SLC2A1 mediates the Warburg effect

Author

Lopez-Serra, Paula, Marcilla, Miguel, Villanueva, Alberto, Ramos-Fernandez, Antonio, Palau, Anna, Leal, Lucía, Wahi, Jessica E., Setien-Baranda, Fernando, Szczesna, Karolina, Moutinho, Catia, Martinez-Cardus, Anna, Heyn, Holger, Sandoval, Juan, Puertas, Sara, Vidal, August, Sanjuan, Xavier, Martinez-Balibrea, Eva, Viñals, Francesc, Perales, Jose C., Bramsem, Jesper B., Ørntoft, Torben F., Andersen, Claus L., Tabernero, Josep, McDermott, Ultan, Boxer, Matthew B., Vander Heiden, Matthew G., Albar, Juan Pablo, and Esteller, Manel

Published
2016
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results